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Abstract
Trianthema portulacastrum  L. (Biskhapra/ Horse purslane) is widely found in tropical and sub-
tropical  countries of  the world. This weed automatically spread in cultivated fields. From the
ancient time it is used for curative purposes. The plant pertains wide range of applicability and
henceforth used as an Ayurvedic herb.  The decoction of  this  herb is utilized as  a vermifuge,
antidote prepared from that helps in treating alcohol poisoning and leaves cure the wound. In the
era of phytomedicines lot of work has been done related to its morphology,  ethno-pharmacology,
medicinal uses,  phyto-chemistry  and  pharmacological  properties.  Various  pharmacological
properties  like  antimicrobial  properties,  analgesic,  anti-inflammatory,  anti-diabetic,  anti-
hyperglycemic, hepato-protective activity makes this plant very renowned amongst researchers
as  they  utilized  it  somewhat  like  a  panacea.  Different  parts  of  plants  are  utilized  for  the
therapeutic purposes and extract prepared in different solvents used in the treatment of various
disorders. In this review, an attempt has been made to provide all inclusive information of this
plant about its bioactive compounds and their pharmacologoical importance. 
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Introduction
Trianthema portulacastrum L. (TP) is one of the most
important members of Aizoaceae family (1).  Other
than  this,  20  more  species  are  reported  from  the
similar  genus  Trianthema,  which  is  an  annual  or
perennial  plant  and  various  researches  reported
about  the  therapeutic  potential  of  this  species.
Various parts of this plant are used for the isolation
of  drugs  and  bioactive  compounds  (2).  T.
portulacastrum is  a  flowering  plant  commonly
known  as  Horse  purslane,  Biskhapra  and  Giant
pigweed  (3).  It  is  broadly  distributed  in  tropical
countries and is native to continents Africa,  South
and  North  America  Southeast  Asia.  This  review
shows  the  evaluation  of  occurrence,  morphology,
ethnopharmocology,  ecological,  biodiversity,
phytochemistry,  medicinal  uses,  toxicity  and
pharmacological activities about  T. portulacastrum.
The Broad classification is tabulated in Table 1 (4).
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Table 1. Taxonomical Classification (3, 23)
Domain : Eukaryota
Kingdom : Plantae (Plants)
Sub-kingdom : Tracheobionta (Vascular plants)
Division : Magnoliophyta (Flowering plants)
Superdivision : Spermatophyta (Seed plants)
Class : Magnoliopsida (Dicotyledons)
Subclass : Caryophyllidae
Order : Caryophyllales (Herbaceous and fleshy)
Family : Aizoaceae (Fig-marigold family)
Genus : Trianthema L.
Species : Trianthema portulacastrum L.
Distribution and occurrence
T.  portulacastrum is  an  exotic  weed,  native  to
tropical  America  but  geographically  occurring  at
most of the tropical, subtropical habitats, generally
distributed in Saudi Arabia, Bangladesh, Sri Lanka,
Africa China, Egypt,  Uganda, Ghana,  Mali,  Congo,
New  Jersey,  Nevada,  Utah,  Virginia,  Costa  Rica,
Peru,  Chile  as  shown  in  Fig.  1  (5,  6).  In  India
Biskhapra is naturalized throughout the cultivated
fields,  river beds,  waste ground especially in the
states of central and northern zone in which areas
of Delhi,  Rajasthan, Punjab and Uttar Pradesh.  It
thrives  better in  saline soil  than that  of  alkaline
soil  (7).  It  is  very  common  and easily  visible  in
agricultural  and  vegetable  crops  such  as  pigeon
pea, mung bean, cotton, pearl millete, sugarcane,
soybean,  onion,  potato,  maize,  mustard,  direct-
seeded  rice,  tomato,  oilseed,  pulses  and
horticulture crops in India, Pakistan and Sri Lanka
(8). This weed is reported to be strong competitor
and reducing the yield by  negative allelopathy in
mung  bean  up  to  60%  and  significant  losses  in
soybean, maize and peanut (9). 
Vernacular names of the plant
T.  portulacastrum L.,  commonly  known  as  black
pigweed,  gaint  pigweed,  itcit,  gudbur,  hogweed,
desert  purslane,  horse  purslane  and  lowland
purslane. Apart from these common names, TP is
globally utilized for its broad range of applications.
It is known to people of distinct area by different
regional names which is mentioned in Table 2 (10,
11).   
Morphology
T.  portulacastrum is  the  prostrate  herb  (Fig.  2)
grows  up  to  an  average  height  of  40  cm,  it  is
pubescent,  diffuse,  prostrate,  profusely  branched
species developed in mats or clump with stems and
propagation  occurs  very  rapidly  on  cutting  (12).
Leaves are of 1.5 - 2.5 cm, stem is green in color,
ascended,  hispid,  cylindrical,  rounded,  hairy  and
fleshy.  Mature  stem  comprises  of  five  successive
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Fig. 1. Map showing distribution of TP all across the world.
Fig. 2. T. potulacastrum L. (A. Root, B. Leaf, C. Seed, D. Stem).
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rings of cambium having fusiform cells, devoid of
xylem rays  and only  consist  of  tracheids,  vessels
and fibers  which help in  transportation  of  water
(13).  Leaves  are  simple,  fleshy,  entire,  broad,
opposite,  uneven,  ovate-ovate,  petiole  dilated
enclosing  the  stem,  single  mid-rib,  dorsiventral,
having  two-layered  palisade  tissue,  pinnately
veined, green in colour and 2 cm long, 3 cm wide
attached to the plant via 1 cm short petioles (14). It
bears  pink or purple  and rarely  whitish bisexual
flowers and 1-3 in number. Flowering season of T.
portulacastrum is  approximately  for  five  months
which is from June to October, they bloom generally
in morning hours and they are small in size with
horn-like appendages with stipules and have green
bracts  generally fused with leaf bases with white
sepals. Root is greenish-yellow from outside and is
white in color from inside (15).
Table 2. Vernacular Names (3, 57) 
Language  Local name
Arabic Zaleya Pentandra, Hamd Qooqi
Bengali Godabani, Sabuni, Kulphasag, Swet punarnova
Chinese Jia Hai Machi
English Giant pigweed, Desert Horse purslane, Carpetweed
Indonesia Subang- subang
Kannada Muchchugoni, Pasalaesoppu, Sihi Punarnava
Hindi Sabuni, Svetsabuni, Salsabuni,Vishakhapara, Saphed Punamava
Malayalam Tavilama, Talutama, Sharunnau, Pasalikeera, Thazhuthama, Jamizhama
Marathi Pundhari-ghentuli, Pundharighetntuli
Nepali Setopunarnava
Oriya Dewasapt
Punjabi Biskhapra, Itsit, Sanaya
Sanskrit Dhanapatra, Chiratika, Upothaki, Vishakha Shvetamula, Dirghapatrika                                           
Sindhu Sweta puruni, Luduru sas
Spanish Verdolaga
Tamil Sharunnai, Charu velai, Shavalai, Shaaranaj, Mukuruttai
Telugu Ghelijeru, Ambatimadu, Galijenu, Atikamamidi
Thai Phak biahin
Urdu Narma, Biskhapra
Unani Lotoos Aghryoos
Vietnamese Sam bien, Cotam khoi, Rau sam gia
Ethnopharmacology
T. portulacastrum is popularly used throughout the
globe due to its pharmacological  activities against
many disorders  or diseases.  Leaf  extract  of  plant
possesses antioxidant properties and act as poultice
which is useful in the healing of wound (16), curing
the  chronic  pain  of  osteoarthritis  disease  and  its
diuretic action help in curing edema (17),  jaundice,
strangury and also used to treat ascites and beriberi
(18).  Asthma and alcohol  poisoning are  cured by
using  decoction  of  leaves  which  carry
antihelminthic  properties,  help  in  curing  heart
diseases,  piles and also used as a vermifuge (19).
Dried leaves used in treatment of Gonorrhea. Roots
are abortifacient in high concentration whereas in
optimum  concentration  its  decoction  used  as an
emmenagogue,  it  also  cure  liver  obstruction,  eye
inflammation,  asthma  and  relieve  from
constipation. Leaves of plant are used with soups
and vegetables in African countries like Tanzania
and Ghana (21).
Phytochemistry
Screening method help in determination of number
of  remarkable  phytochemicals  like  alkaloid,
carbohydrates,  flavonoid,  phenolic  compounds,
steroid  and  terpenoid  (22),  Photoecydosone  in
different parts of plant T. portulacastrum L. which
is  used  for  various  therapeutic  and  medicinal
purposes  (2).  This  plant  is  also  a  rich  source  of
organic and inorganic components such as calcium
(Ca),  magnesium  (Mg),  nitrogen  (N),  Iron  (Fe),
Zinc(Zn), phosphorus(P),  ascorbic acid (Vitamin C)
and nicotinic acid (Vitamin B) (24) and this species
comprised of excellent amount of fiber along with
other nutrients which make it useful for animals as
a food in the form of fodder while other species of
genus  Trianthema  are  rich  in  fats.  Most of  these
species phosphorus and iron present in abundance
whereas calcium is present in low percentage. The
mineral profile of TP is tabulated in Table 3. 
Table 3. Mineral profile of T. portulacastrum L.
Content Quantity present References
Protein 21.50% (52, 53)
Neutral Lipid 95. 2% (54)
Polar Lipid 4.80% (54)
Crude Fibre 43% (54)
Carbohydrate 30.20% (52)
Hydrocarbons 0.30% (54)
Vitamin A 0.081 mg/100gm (54)
Vitamin C 0.202 mg/100gm (54)
Carotene 2.3 mg/100gm (53)
Calcium 52 mg (55)
Chromium 0.200 mg (56)
Copper 8ppm (52)
Iron 6.44mg/kg (55)
Magnesium 153mg (56)
Manganese 40 mg/kg (55)
Nickel 0.03 mg/gm (54)
Phosphorus 22 mg (56)
Potassium 51.6 mg /gm (54)
Sodium 44 mg /gm (54)
Zinc 30 ppm (54)
Phytochemical  screening  by  using  the
methanol, chloroform and water extract helped in
the  determination  of  photochemicals  which  are
acetylaleuritolic  acid  (25),  dimethoxycinnamic
acid,  5,7-dihydroxy 6 8 dimethylchromone‐ ‐ ‐
(Leptorumol),  dihydroxy 7 methoxy 6 8 dimethyl‐ ‐ ‐ ‐ ‐
flavones,  5 hydroxy 2 methoxybenzaldehyde,  p‐ ‐ ‐ ‐
methoxybenzoic acid, Quercetin and plays a major
role in drug development (Fig. 3). 
T.  portulacastrum  flower  consists  of
alkaloid  punarnavine  (26).  These  phytochemicals
are reported in the aerial parts of the plant (27).
Presence  of  dichloromethane  in  the  extract  of
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dried leaf reported new flavonoids, 5,2′-dihydroxy-
7-methoxy-6,8-dimethyl  flavones  (C-
methylflavone),  5,7-dihydroxy-6,8-
dimethylchromone (leptorumol)  and its  structure
is  been  reported  by  X-ray  analysis.  Red  color
pigment  β-Cyanin is  one  of  the  prominent
flavanoid  of  T.  portulacastrum.  Qualitative
analysis  by  chromatographic  separation  of  plant
extract gave mixtures of sterols which are  stigma
sterol,  β-sitosterol  and  their  β-glucopyranosides.
An  important  tetraterpeniod  named  trianthenol
with antifungal properties reported in chloroform
extract (28). 
Pharmacological activities
T.  portulacastrum is  a  medicinal  weed  which
shows  many  recognizable  pharmacological
activities  like  antimicrobial,  antiparasitic,  anti-
inflammatory,  antioxidant,  diuretic,
antihyperglycemic,  antipyretic  and  cancer-
preventive  therapeutic  properties  that  are  been
depicted  in  (Fig.  4).  It  is  also  reported  for
combating other disorders such as gastrointestinal,
jaundice,  edema,  hormonal,  cardiovascular  and
skin-related diseases (29).
Analgesic activity
Evaluation  of  ethanolic  extract  of  plant  T.
portulacastrum was done and outcome it showed
its  antinociceptive activity  in  mice.  The  effect  of
analgesic activity was checked by introducing the
doses  for  central  and  peripheral  analgesic  like
morphine,  aspirin  and streptomycin.  Which  was
found to be inactivate of pain relief, the effect of
plant extract showed close value to that of aspirin
which  seems  to  help  in  blocking  of  writhing
response gave value of P less than 0.005 (P<0.005)
(30).
Antifungal activity
It was reported that horse purslane extract against
F.  chlamydosporum found  to  be  very  effective
which  causes  leaf-spot  disease  in  the  plants.
Besides,  many  reports  admitted  that  the  both
chloroform  extract  of  plant  and  well  known
phytochemical trianthenol (Tetraterpenoid) shows
the antifungal activity (31). 
Anticarcinogenic activity
The chloroform extract  and ethanolic  extracts  of
the  plant  showed  reliable  result  in
chemoprotective activity as clearly manifested in
(Table  4).  When  in  mice  a  potent  carcinogen
named,  DENA  (diethylnitrosoamine)  was
introduced  that  induced  hepatocancer  in  a  mice
model and this chemical reduces the nodules size
of  rat’s  liver.  The dose of  plant  extract  which  is
been prepared in  ethanol  reviled the  best  result
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Fig. 3. Structures of various phytochemicals present in T. portulacastrum L.
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than  that  of  chloroform,  inhibiting  cell
proliferation  and  also  suppressed  the  effect
chemical  DENA.  It  was  effective  in  reducing
carcinogenic activity up to 25% and acted as most
active in inhibition of hepatic cancer (32).
Antifertility activity
T. portulacastrum has been well known for its anti-
fertility  properties  because  of  the  presence of
phytochemical  like  steroid  and  ecdysterone  that
has been naturally present. Hence, it is employed
as a contraceptive and abortifacient by some rural
peoples  and  tribal  communities  of  India.  This
tendency was studied in aqueous, chloroform and
alcoholic  extracts  of  plant,  to exhibit  antifertility
activity.  It  was  found  that  alcoholic,  chloroform
and aqueous extract perform 94%, 73% and 64%
abortifacient  activity.  From  this,  it  was  clearly
depicted that alcoholic extract is most potential as
antifertility agent (33).
Antihyperlipidemic property
When there is a rise in concentration of lipids such
as phospholipids,  cholesterol or triglycerides due
to  factors  like  fatty  diet,  intake  of  drugs  and
genetic defects causes hyperlipidemia (34). Against
this  hyperlipidemia,  the methanolic  extract  of  T.
portulacastrum manifested  antihyperlipidemic
activity and hence used to develop hypolipidemic
drugs  from  natural  sources  to  prevent  the
individual from cardiovascular diseases (35). 
Plant  extract  of  T.  portulacastrum
significantly  used  to  cure  diabetes  mellitus.
Methanol  extract  of  T.  potulacastrum (METP)
shows antihyperglycemic  activity  in diabetic  rats
which  is  been  produced  by  injecting  dose  of
streptozotocin-induced  diabetic  rats.
Demonstration  of  antihyperglycemic  activity  by
the extract is done by lowering down the glucose
level  which  is  being  monitored  in  diabetic  rats
(36).
Antimicrobial properties
Some  reports  depicted  that  T.  portulacastrum
possessed  antimicrobial  properties  and  found  to
be effective against both gram positive and gram-
negative bacteria, fungi and helminthes because of
the presence of photochemical  available  in plant
(37).  Plant  extract  prepared  from  roots  showed
antimicrobial  property  against  bacteria  Bacillus
subtilis,  Escherichia  coli,  Proteus  vulgaris and
Staphylococcus  aureus. Phytochemical  screening
confirmed  the  presence  of  alkaloid,  flavonoid,
sterols  and  phenolic  compounds  in  the  plant.
Further attribution to the research explored that
fraction  of  flavonoid  of  plant  T.  portulacastrum
performed  better  antimicrobial  and  antifungal
propertied, based on zone of inhibition than that
of  phenolic  and  alkaloid  fractions  in  the
methanolic extract (38).
Nephroprotective effects
Nephroprotective effects has been studied in renal
damaged mice against whom methanolic extract of
T.  portulacastrum pertained  nephroprotective
action because of its DPPH-free radical scavenging
and  antioxidant  property.  Renal  damaged  mice
developed  in  an  experimental  model  by
Adriamycin in against which the extract improved
the histopathological  effects that was caused due
to disease condition (39).
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Fig. 4. Overview of pharmacological properties of TP. 
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Chemosterilants/ molting hormone activity
T.  portulacastrum contains  well  known
phytoecdysteroids called  Ecdysteroids.
Ecdysterone  and  its  analogs  tend  to  stimulate
protein  synthesis  in  mammals  as  well  as  in
arthropods  and  hence  act  as  a  chemosterilants
(40). Larva of Musca domestica (housefly) selected
as  a  model  for  the  experiment  to  check  molting
hormone  activity  of  plant  in  which  abdomen  of
model is dipped in plant extract and responded by
the  formation  of  pupanum  just  by  0.01  μg
ecdysterone dose (41). 
Antipyretic activity
The rise  in body temperature that  is  more than
38.3  °C  is  known  as  pyrexia  or  fever,  acute
infection  body  respond  against  this  alleviated
temperature  by  releasing  cyclo-oxygenase  from
prostaglandins (42).  But this response doesn’t go
for  prolonged or  chronic infection  recorded the
antipyretic  activity  of  T.  portulacastrum.  In  his
experiment,  yeast-stable pyrexia was induced in
rats against which antipyretic activity was shown
by ethanol extract of T. portulacastrum (43).
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Table 4. In vivo investigation of anti-carcinogenic property of plant T. portulacastrum.
Sl.
No.
Plant
Extract 
Exp.
Model 
Disease
Targeted 
Toxic
control Dose Route Duration Investigation Results Ref.
1 Ethanolic 
extract of 
stem and 
leaves
Female 
Sprague-
Dawley 
rat
Mammary 
carcinogen
esis
7, 12-
dimethylbe
nz(a)anthra
cene
50, 100 
and 200
mg/kg
p.o. 18 weeks Suppressed 
proliferating cell 
nuclear antigen 
and cyclin D1 
expression, 
induced 
apoptosis
Strong anti- 
carcinogic 
compounds
 (54)
2 Chloroform 
extract of 
stem and 
leaves
Male rat 
(Sprague-
Dawley) 
Hepatocar
cinogenesi
s 
DENA-
initiated 
100 mg/
kg/day
p.o. 4–20 
weeks 
Decrease in 
Nodule incidence 
and multiplicity 
as well as 
decrease nodular 
volume and area.
Reduced liver cell
foci/cm2 and focal
area
Ppotential of  anti-
carcinogenic 
 (53) 
3 Ethanolic 
extract
Wistar 
albino 
rats
Breast 
cancer
50, 100 
and 200
mg/kg 
b.w 
16 weeks TP suppressed 
proliferating cell 
nuclear antigen 
and cyclinD1 
expression, 
induced 
apoptosis, down 
regulated 
antiapoptotic 
protein Bcl-2 and 
diminished the 
expression of 
nuclear and 
cytosolic b-
catenin in 
mammary 
tumors
Exerted 
chemopreventive 
effect in the 
classical DMBA 
model breast 
cancer
 (50) 
4 Ethanolic 
extract  
Wistar 
albino 
rats
Mammary 
carcinogen
esis 
7,12- 
Dimethylbe
nz(a)anthra
cene 
(DMBA)
50, 100 
and 200
mg/kg 
16 weeks TP down 
regulated the 
expression of 
cyclooxygenase-2 
and hsp 90, 
blocked the 
degradation of 
inhibitory kappa 
B-alpha
Induced breast 
neoplasia by anti-
inflammatory 
mechanisms
(50) 
5 Aqueous 
ethanol and 
choloroform 
extract 
Male 
Sprague 
Dawley 
rats
Hepatocar
cinogenesi
s 
Diethylnitro
soamine 
(DENA)
100 mg/
kg 
p.o. Daily for 
22 weeks 
TP increased 
glutathione levels
and the levels of 
Phase I 
(cytochrome P-
450 
monooxygenase) 
and Phase II 
(UDPGT) 
enzymes. 
Decrease in lipid 
peroxidation 
TP exerted as 
strong 
anticarcinogenic 
compounds
(52)
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Antioxidant properties
Plant  extract  of  T.  portulacastrum is  enriched
with many antioxidant compounds out of which
the major one is Gallic acid which is reported as
50 mg in roots, 75 mg in shoots and 98.09 mg in
leaves that is equivalents to per gram dry weight
of plant (44). From the above statement it is clear
that  leaf  extract  of  plant  persist  highest
antioxidant  properties  over  root  and shoot.  The
ethanol extract of leaves was chosen for further
investigation  for  the  antioxidant  properties  and
in  rats  it  showed  the  relation  with
thioacetanamide,  hepatotoxins  and paracetamol.
Reactive  oxygen  species,  free  radical  and
oxidative  stress  cause  many  degenerative
diseases  in  an  individual  and  also  damage  the
body organs as well  as genomic material.  These
oxidant  species  lowering  the  concentration  of
antioxidant  enzyme  like  catalase  (CAT),
glutathione  reductase  (GSH-R),  glutathione
peroxidase  (GPX),  superoxide  dismutase  (SOD)
and  glutathione-S-transferase  (GST)  but  after
treatment with plant extract, enzymes attain the
normal concentration in the experimental model
and prevented from diseased condition (45).
Diuretic Properties
In  India  T.  portulacastrum is  commonly  been
used for  ethnomedicinal purposes because of its
diuretic  activity.  When diuretic  activity  of plant
extract  compared  with  standard  diuretic  that  is
furosamide than it gave 79% result in response to
the plant dose of concentration 50 mg/kg and also
produces kaliuretic and natiuretic effects (46). A
similar  investigation  was  done  and  reported  in
further  investigations.  Researchers  are  still  far
from  mechanism  but  certainly  it  is  due  to  the
presence of phytochemicals in plant (43).
Hepatoprotective effects
Hepatotoxicity  has  been  induced  in  albino  rats
by  introducing  familiar  hepatotoxins
thioacetamide  and  paracetamol  in  response  to
which  ethanolic  extract  showed  anti-
hepatoprotective  activity  (47).  The  intake  of
higher amount of paracetamol promotes hepatic
necrosis  and  also  prescribed  as  an  antipyretic
and analgesic agent. Against these hepatotoxins
T.  portulacastrum stimulated  regeneration  of
hepatic  cells  and  also  promoted  detoxification
(48).
Antiglomerulosclerosis
During  glomerulosclerosis  there  is  a  rise  in  the
level  of  creatinine  and  enzymes  aspartate,
transaminases and alanine. To overcome this, 100
and  200  mg/kg  of  methanolic  extract  of  plant
provided  protection  in  experimental  model  rats
against  diet  that  induced glomeruloscelerosis.  It
also  pertain  protective  property  against  hepatic
damage, CCT (4% cholesterol, 1% cholic acid and
0.5% thiouracil) and antherosclerotic disease (49).
Mosquito larvicidal activity
Aqueous  and  acetone  extract  of  plant  T.
portulacastrum persisted  best  larvicidal  activity
and 100% mortality rate has been found at third
stage of instar larvae at different concentration of
on different species of mosquitoes which includes
Culex  quinquefaciatus,  Anopheles  culcifacies,
Anopheles  stephensi and  Aedes  aegypti. On  the
basis of LD50 and LD90 values of larvae of different
mosquitoes it was concluded that acetone extract
pertained  better  larvicidal  activity  over  crude
aqueous extract of experimental plant (20).
Mammary tumor genesis
Breast tumor was developed upon introduction of
40,  50  and  100  mg/kg  concentration  of  7,  12-
dimethylbenz (a)  and anthracene (DMBA) in the
mice  by  supplementing  with  diet.  Ethanolic
extract of T. portulacastrum reported to suppress
the  activity  of  DMBA  which  initiate
tumorigenesis.  It  also  helped  in  proliferating
expression of cyclin D1, upregulated propoptotic
protein Bax, downregulated antiapoptotic protein
Bcl2  and  induced  apoptosis  by  regulating  or
changing  the  ratio  of  proteins  Bax  and  Bcl2.  It
diminished  the  irregular  and  abnormal  cell
proliferation  and  canonical  Wnt  signaling
pathways which showed oncostatic effects (50).
Anti-inflammatory Properties
Chloroform extract of  T. portulacastrum induced
anti-inflammatory  effects  and  resist  58.36%  of
inflammation of rat paw edema assay induced on
animal by carrageenans which release histamine
and 5-hydroxy histamine initially and then kinin
and  prostaglandin  in  latter  phase.  Same  as  in
dextran  plant  shows  resistivity  against
inflammation  which  also  induce  paw  edema  as
that of carrageenans but other than histamine, it
is  also  mediated  by  serotonin  which  is
inflammation  mediators  in  nature  and  help  to
suppress  inflammation.  The  anticancerous
properties  are  also  directly  or  indirectly  linked
with  anti-inflammatory  potential  of  plant.  By
lowering  the  inflammatory  stress  response
inhibition  of  Chemical  Dimethylbenzanthracene
(DMBA)  is  done  which  induces  the  breast
tumorogenesis (51).
Antilithic activity 
Antiliathic  activity  inhibits  the  formation  of
kidney  stones  and  help  in  getting  rid  its
symptoms.  When  urolithiasis  is  experimentally
induced  in  model  it  causes  the  formation  of
kidney  stone  which  get  cure  on  treating  the
animal  with  ethanolic  extract  of  T.
portulacastrum made from leaves (45).
Conclusion
Based on this review, it can be concluded that the
distinct parts of plant T. portulacatrum employed
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to  perform  various  functions.  Detailed
comparative physicochemical and phytochemical
studies  on  different  parts  of  T.  portulacatrum
reported and the data justified the applicability of
this  plant  in  traditional  systems  of  medicine.
Natural and herbal drugs are recognized as safe
but can also lead to adverse reactions, therefore
correct identification and adulteration can help to
validate it as potential drug candidate.  Different
polyphnolics  isolated from the  extract  prepared
in  different  solvents  which  seems  to  persist
number  of  pharmacological  properties  such  as
antimicrobial,  analgesic, anti-inflammatory, anti-
diabetic,  anti-hyperglycemic,  hepato-protective
activity and help in curing many disorders. This
review is an effort to bring all  the properties of
this  plant  together  that  was  reported  at  times.
This  report  explored  important  therapeutical
properties  of  this  herb  and  its  curative  nature
which  converge  the  interest  of  researchers
towards  this  plant.  This  study  finally  concludes
that  T.  portulacastrum L.  is  an  unusual  and
unbelievable  source  with  so  much  to  offer  the
world of medicine.   
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